Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Sanofi Pasteur is paying $45 million up front to Lexington, Mass.-based Translate Bio, formerly known as RaNA Therapeutics, to develop messenger RNA (mRNA) vaccines for up to five infectious diseases. The vaccines could allow the body to use its own protein-making machinery to develop an immune response to the proteins translated from the mRNA. Translate could receive up to $760 million in additional milestone payments. Sanofi also has an ongoing partnership with BioNTech to develop cancer immunotherapies based on a similar mRNA technology.
This article has been sent to the following recipient: